ப்ரொஃபெஸர் கிஂக்ஸ்‌டந் ஆலைகள் ஆஃப் திரித்துவம் கல்லூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

From Ireland’s point of view, there are favourable developments this week. Oxford-AstraZeneca applied to the European Medicines Agency for approval and a decision is due on January 29. The hope is there will be a generous series of shipments of some of the 3.3 million doses ordered of the easy-to-use jab. It is given in two doses but can be stored at regular temperatures, making it easy for GPs and pharmacists to administer. Johnson and Johnson also indicated its vaccine is near the end of its trials, which could mean an application in February. It is delivered in one dose. Ireland is lucky that Pfizer-BioNTech has been so efficient and reliable, allowing the roll-out of the vaccine to be jumpstarted with 40,000 doses a week until the end of February.

Stephen donnellySandra gallinaEuropean unionEuropean medicines agencyProfessor kingston mills of trinity collegeMinister stephen donnellyKingston millsTrinity collegeஸ்டீபன் டோநிலீசாண்ட்ரா கல்லினாஐரோப்பிய தொழிற்சங்கம்ப்ரொஃபெஸர் கிஂக்ஸ்‌டந் ஆலைகள் ஆஃப் திரித்துவம் கல்லூரிஅமைச்சர் ஸ்டீபன் டோநிலீகிஂக்ஸ்‌டந் ஆலைகள்திரித்துவம் கல்லூரி